Metformin er en oral antidiabetisk medicin som anvendes til at behandle type 2 (ikke-insulinafhængig) diabetes. Behandlingen kombineres med diæt og motion. Medicinen kan anvendes alene eller sammen med andre midler mod diabetes.

Metformin Extended-Release is an oral antidiabetic medication used to treat type 2 (non-insulin-dependent) diabetes.

Generic ActoPlus Met is used for treating type 2 diabetes. It is used along with diet and exercise. It works by decreasing the amount of sugar the liver produces and the intestines absorb.

Galvumet is a combined medicine that contains two active components 50mg of vildagliptin and 1000mg of metformin. This pharmaceutical is indicated as an adjunct to diet and exercise to improve glycaemic control in patients whose diabetes is not adequately controlled on metformin hydrochloride alone or who are already treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. Treatment should not be initiated with this fixed-dose combination. Also Galvumet is assigned in combination with a sulfonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulfonylurea. As well, Galvumet is prescribed as add-on to insulin as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Generic Glucovance is used for treating type 2 diabetes. It is used along with diet and exercise. It may be used alone or with other antidiabetic medicine.

Generic Janumet and sitagliptin are oral diabetes medicines that help control blood sugar levels. Generic Janumet works by decreasing glucose (sugar) production in the liver and decreasing absorption of glucose by the intestines. Sitagliptin works by regulating the levels of insulin your body produces after eating

Jentadueto er et lægemiddel, der indeholder de aktive stoffer linagliptin og metforminhydrochlorid. Den fås som tablets. Jentadueto anvendes til voksne med type 2-diabetes for at forbedre kontrollen af blodsukkerniveauet. Det bruges som supplement til diæt og motion hos patienter, der ikke er tilfredsstillende kontrolleret med metformin anvendt alene, til patienter, der allerede tager en kombination af linagliptin og metformin som separate tabletter, i kombination med et sulfonylurinstof eller insulin til patienter, som ikke er tilfredsstillende kontrolleret med denne medicin og metformin.

Jentadueto XR er oral diabetesmedicin, der hjælper med at kontrollere blodsukkerniveauet. Metformin virker ved at nedsætte produktionen af glukose (sukker) i leveren og nedsætte absorptionen af glukose i tarmene. Linagliptin virker ved at regulere niveauet af insulin, som din krop producerer efter at have spist. Jentadueto XR er en kombinationsmedicin, der bruges sammen med diæt og motion for at forbedre blodsukkerkontrollen hos voksne med type 2-diabetes mellitus. Jentadueto XR er ikke til behandling af type 1-diabetes.

Metformin and saxagliptin are oral diabetes medicines that help control blood sugar levels. Metformin works by decreasing glucose (sugar) production in the liver and decreasing absorption of glucose by the intestines. Saxagliptin works by regulating the levels of insulin your body produces after eating. Metformin and saxagliptin is a combination medicine that is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. This medicine is not for treating type 1 diabetes.

Kombiglyze XR® indeholder kombination af metformin og saxagliptin. Metformin og saxagliptin er orale lægemidler mod diabetes, der hjælper med at kontrollere blodsukker. Metformin virker ved at hæmme produktion af glucose i leveren og absorption af glucose fra tarmen. Saxagliptin virker ved at regulere insulin, som din krop producerer efter at have spist. Kombiglyze XR bruges sammen med kost og motion for at forbedre kontrol af blodsukker hos voksne med type 2-diabetes mellitus.

Generic Metaglip is used for lowering blood sugar levels in combination with diet and exercise in patients with type 2 diabetes.

Galvus is a medicine that contains the active substance vildagliptin. It is available as tablets (50 mg).Galvus is used to treat type-2 diabetes mellitus. It can be used on its own (monotherapy) in patients whose diabetes is not sufficiently controlled by diet and exercise and who cannot take metformin; also, together with metformin, a thiazolidinedione or a sulphonylurea (dual therapy) when the patient’s diabetes is insufficiently controlled by this other medicine taken alone, but it is only used in combination with a sulphonylurea in patients who cannot take metformin. As well it is used together with a sulphonylurea and metformin (triple therapy) in patients whose diabetes is not sufficiently controlled by these medicines plus diet and exercise; also together with insulin (with or without metformin) in patients whose diabetes is not sufficiently controlled by diet and exercise plus a stable dose of insulin.